Influence of cirrhotic cardiomyopathy on long-term outcomes and clinical findings including portal hemodynamics in cirrhosis

Influence of cirrhotic cardiomyopathy on long-term outcomes and clinical findings including portal hemodynamics in cirrhosis - Cirrhotic cardiomyopahty and portal hemodymics

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016566

Enrollment

160

Registered

2015-02-17

Start date

2015-02-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with cirrhosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with cirrhosis

Exclusion criteria

Exclusion criteria: patients with use of beta-blockers patients with hisotry of TIPS/Denver shunt patients with arterio-portal shunt patients with habitual drinking (> 20g/day)

Design outcomes

Primary

Measure	Time frame
Relationship between decompensation/liver function/portal hemodynamics and cirrhotic cardiomyopathy	—

Secondary

Measure	Time frame
Influence of cirrhostic cardiomyopahty on prognosis and decompensation in cirrhosis	—

Countries

Japan

Contacts

Public ContactHitoshi Maruyama

Chiba University Graduate School of Medicine Gastroenterology and Nephrology

maru-cib@umin.ac.jp043-222-7171

Outcome results